Thromb Haemost 1961; 6(02): 248-253
DOI: 10.1055/s-0038-1654557
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Relation between a Naturally Occuring Inhibitor and Prothrombin in Intermediate Product I Formation

E. T Yin
1   Coagulation Laboratory (Prof. F. Koller) of the Department of Medicine (Prof. P. H. Rossier) Kantonsspital, University of Zürich, Switzerland
,
J. N Shanberge*
1   Coagulation Laboratory (Prof. F. Koller) of the Department of Medicine (Prof. P. H. Rossier) Kantonsspital, University of Zürich, Switzerland
,
F Duckert
1   Coagulation Laboratory (Prof. F. Koller) of the Department of Medicine (Prof. P. H. Rossier) Kantonsspital, University of Zürich, Switzerland
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

Preview

Summary

1. A method for the separation from clotting factors and the concentration of an inhibitor of intermediate product I present in adsorbed plasma and adsorbed serum is described.

2. This inhibitor is not only stable but also activated at 37° C. At 4° C it loses activity.

3. The inhibitory effect on the formation of intermediate product I is counteracted by small amounts of prothrombin or thrombin.

4. After addition of inhibitor prothrombin is necessary for the formation of intermediate product I in the purified system.

5. The discrepancy, in regard to the need for prothrombin (or thrombin) between the purified and the non-purified system can be explained by the relative amounts of inhibitor in the two systems.

* Investigation carried out during the tenure of a Special Fellowship from the American Heart Institute, United States Public Health Service.